April 17, 1990 |
Makers of ibuprofen medicines disputed conclusions of medical experts who claim a 12-patient study by doctors from Johns Hopkins University in Baltimore indicates over-the-counter doses of the painkiller may cause kidney failure in high-risk people. The study was published in the Annals of Internal Medicine.
March 30, 1995 |
High doses of a common over-the-counter pain reliever slowed lung deterioration by 90% over four years in children with cystic fibrosis, a study has found. The benefits of ibuprofen--sold under such brand names as Advil, Nuprin and Motrin--were most dramatic in children ages 5 to 13 who consistently took it in addition to conventional treatment with other drugs, the study's authors said. Ibuprofen might also have some reduced benefit in older patients, the researchers said.
March 10, 1997 |
The risk of developing Alzheimer's disease can be reduced by as much as 60% by frequent consumption of the common anti-inflammatory drug ibuprofen over two years or longer, a massive study to be released today has shown. Even shorter use could reduce the risk by as much as 35%, a team from Johns Hopkins University and the National Institute on Aging reports in the journal Neurology.
February 15, 1991 |
The widely used pain reliever ibuprofen doubles the risk of ulcers, according to Vanderbilt University researchers, and some experts say that people taking it may want to consider lower doses or alternatives. But for those suffering chronic pain and inflammation, researchers said ibuprofen may be the best choice because it has the lowest ulcer risk among the drugs studied. Those drugs belong to a prescription class called non-steroidal anti-inflammatory drugs, or NSAIDs.
March 27, 1993 |
For years, aspirin king Bayer stood by as substitute analgesics, such as ibuprofen and acetaminophen, took increasingly larger shares of the $2.2-billion over-the-counter pain-reliever market. Like a sleepy giant finally roused to action, Bayer is now attacking the market with a vengeance, having launched a $116-million campaign to introduce and promote five new Bayer products. None of the new "Bayer Select" products is aspirin-based--a tacit admission by Bayer that aspirin is no longer king.
August 8, 1985 |
Johnson & Johnson, which since 1982 has been rocked by a series of developments affecting its products and finances, said Wednesday that profit for the next two years "appears to be in pretty good shape." While declining to make a specific forecast, Chairman and Chief Executive James E. Burke said strong profits for 1985 and 1986 will result largely from productivity gains and sharply reduced spending to market consumer products.
November 5, 1991 |
Headache? Take an aspirin. Wait a minute--what was it you just heard? Oh, go ahead, take that aspirin. All things considered, I would. Aspirin, the quintessential over-the-counter pill, has had remarkable staying power in its 100 years in America's medicine chest. Under a host of trademarks--some avoiding mention of its active ingredient--aspirin has been hailed for its curative powers, and reviled because the company that held the original patent, Bayer, once had ties with I. G.